Stock Events

Bonesupport Holding AB 

SEK298
4
+SEK3.4+1.15% Friday 15:29

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
19.58B
P/E Ratio
67.57
Dividend Yield
-
Dividend
-

Earnings

11JulConfirmed
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q2 2022
Q1 2024
Q2 2024
-0.25
-0.17
-0.08
0
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BONEX.ST. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap129.88B
Stryker Corporation is a competitor due to its extensive range of orthopedic products, including bone substitutes and other materials for bone repair, directly competing with Bonesupport's offerings.
Zimmer Biomet
ZBH
Mkt Cap22.73B
Zimmer Biomet Holdings, Inc. competes in the orthopedic market, offering products for joint reconstruction, bone healing, and dental implants, overlapping with Bonesupport's bone regeneration technologies.
Medtronic
MDT
Mkt Cap101.91B
Medtronic plc offers products for spinal and orthopedic conditions, including bone graft substitutes, competing in the same space as Bonesupport with its bone healing technologies.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson, through its DePuy Synthes division, provides a wide range of orthopedic and neurosurgery products, including synthetic bone grafts, competing with Bonesupport's bone regeneration solutions.
Boston Scientific
BSX
Mkt Cap114.03B
Boston Scientific Corporation competes with Bonesupport through its interventional products, including those for chronic pain and spinal conditions, areas where bone healing products are utilized.
Globant.
GLOB
Mkt Cap8.37B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spine and orthopedic implants that compete with Bonesupport's bone regeneration technologies.
Orthofix Medical
OFIX
Mkt Cap580.2M
Orthofix Medical Inc. offers regenerative and orthopedic solutions, including bone growth therapies, making it a competitor to Bonesupport in the field of bone regeneration and healing.

About

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. The company was founded in 1999 and is headquartered in Lund, Sweden.
Show more...
CEO
Mr. Emil Billbäck
Employees
127
Country
SE
ISIN
SE0009858152
WKN
000A2DTSD

Listings